Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice

British Journal of Nutrition

Volumn 96, Issue 5, 2006, Pages 840-844

  Rault Nania, Marie Hélène ^a   Gueux, Elyett ^a   Demougeot, Céline ^b   Demigné, Christian ^a   Rock, Edmond ^a   Mazur, Andrzej ^a  

^a CRNH AUVERGNE   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Apolipoprotein E deficient mice; Atherosclerosis; Inulin; Oligofructose

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; FRUCTAN; INULIN; SUCROSE; TRIACYLGLYCEROL; OLIGOFRUCTOSE; OLIGOSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIETARY INTAKE; FOOD COMPOSITION; HYPERLIPOPROTEINEMIA TYPE 3; LIPID METABOLISM; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; TREATMENT OUTCOME; ANIMAL; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CARBOHYDRATE DIET; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; LIVER; PATHOLOGY; PHYSIOLOGY; SUGAR INTAKE;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; DIETARY CARBOHYDRATES; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; INULIN; LIVER; MALE; MICE; OLIGOSACCHARIDES; SINUS OF VALSALVA; TRIGLYCERIDES;

EID: 33947433191     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/BJN20061913     Document Type: Article

References (24)

1. Beylot M (2005) Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 93, Suppl. 1, S163-S168.
2. Busserolles J, Gueux E, Rock E, Demigne C, Mazur A & Rayssiguier Y (2003) Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr 133, 1903-1908.
3. Charakida M, Tousoulis D & Stefanadis C (2006) Early atherosclerosis in childhood: diagnostic approaches and therapeutic strategies. Int J Cardiol 109, 152-159.
4. Cherbut C (2002) Inulin and oligofructose in the dietary fibre concept. Br J Nutr 87, Suppl. 2, S159-S162.
5. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH & Brand-Miller J (2005) Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81, 341-354.
6. Delzenne NM & Kok NN (1999) Biochemical basis of oligofructose-induced hypolipidemia in animal models. J Nutr 129, 1467S-1470S.
7. Kaur N & Gupta AK (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci 27, 703-714.
8. Kim M & Shin HK (1998) The water-soluble extract of chicory influences serum and liver lipid concentrations, cecal short-chain fatty acid concentrations and fecal lipid excretion in rats. J Nutr 128, 1731-1736.
9. Kuipers F, van Ree JM, Hofker MH, Wolters H, In't Veld G, Havinga R, Vonk RJ, Princen HM & Havekes LM (1996) Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology 24, 241-247.
10. Mazur A, Remesy C, Gueux E, Levrat MA & Demigne C (1990) Effects of diets rich in fermentable carbohydrates on plasma lipoprotein levels and on lipoprotein catabolism in rats. J Nutr 120, 1037-1045.
11. Meir KS & Leitersdorf E (2004) Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24, 1006-1014.
12. Mortensen A, Poulsen M & Frandsen H (2002) Effect of a long-chained fructan Raftiline HP on blood lipids and spontaneous atherosclerosis in low density receptor knockout mice. Nutr Res 22, 473-480.
13. Napoli C, Palinski W, Di Minno G & D'Armiento FP (2000) Determination of atherogenesis in apolipoprotein E-knockout mice. Nutr Metab Cardiovasc Dis 10, 209-215.
14. Nicoletti A, Kaveri S, Caligiuri G, Bariety J & Hansson GK (1998) Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 102, 910-918.
15. Ranganna K, Yatsu FM, Hayes BE, Milton SG & Jayakumar A (2000) Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells. Mol Cell Biochem 205, 149-161.
16. Roberfroid M (2005) Inulin-type Fructans: Functional Food Ingredients. Boca Raton, FL: CRC Press.
17. Roberfroid MB (2002) Functional foods: concepts and application to inulin and oligofructose. Br J Nutr 87, Suppl. 2, S139-S143.
18. Steinberg FM, Bearden MM & Keen CL (2003) Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc 103, 215-223.
19. Tripathi YB, Singh BK, Pandey RS & Kumar M (2005) BHUx: a patent polyherbal formulation to prevent atherosclerosis. Evid Based Complement Alternat Med 2, 217-221.
20. Williams CM (1999) Effects of inulin on lipid parameters in humans. J Nutr 129, 1471S-1473S.
21. Wouters K, Shiri-Sverdlov R, van Gorp PJ, van Bilsen M & Hofker MH (2005) Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Clin Chem Lab Med 43, 470-479.
22. Wu H, Dwyer KM, Fan Z, Shircore A, Fan J & Dwyer JH (2003) Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Clin Nutr 78, 1085-1091.
23. Xia M, Ling WH, Ma J, Kitts DD & Zawistowski J (2003) Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein E deficient mice. J Nutr 133, 744-751.
24. Zdunczyk Z, Juskiewicz J, Wroblewska M & Krol B (2004) Physiological effects of lactulose and inulin in the caecum of rats. Arch Anim Nutr 58, 89-98.